1. [ACMG](http://www.nature.com/gim/journal/v15/n9/full/gim201392a.html) clinical laboratory standards for next-generation sequencing, Genetics in Medicine, 2013.
2. [A systematic approach](http://onlinelibrary.wiley.com/doi/10.1111/cge.12257/abstract) to assessing the clinical significance of genetic variants, Clin Genet, 2013.
3. Assuring the quality of next-generation sequencing in [clinical laboratory practice](http://www.nature.com/nbt/journal/v30/n11/full/nbt.2403.html), Nature Biotechnology, 2012.
4. Development and validation of [a clinical cancer genomic profiling test](http://www.nature.com/nbt/journal/v31/n11/full/nbt.2696.html) 
based on massively parallel DNA sequencing, Nature Biotechnology, 2013.
5. Tumour heterogeneity [in the clinic](http://www.nature.com/nature/journal/v501/n7467/full/nature12627.html), Nature, 2013.
6. Implementing personalized cancer genomics [in clinical trials](http://www.nature.com/nrd/journal/v12/n5/abs/nrd3979.html), NR Drug Discovery, 2013.
7. Genomics in Clinical Practice: [Lessons from the Front Lines](http://stm.sciencemag.org/content/5/194/194cm5.full), Science Translational Medicine, 2013.
8. Next-generation sequencing [in the clinic](http://www.nature.com/nbt/journal/v31/n11/full/nbt.2743.html), Nature Biotechnology, 2013.
9. [Individualized Medicine](http://www.sciencedirect.com/science/article/pii/S0092867414002049) from Prewomb to Tomb, Cell, 2014.
10. Designing Transformative Clinical Trials in [the Cancer Genome Era](http://jco.ascopubs.org/content/31/15/1834.full), ACO, 2013.
